As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/29/24  Cyclo Therapeutics, Inc.          10-K/A     12/31/23   13:297K                                   RDG Filings/FA           
 3/18/24  Cyclo Therapeutics, Inc.          10-K       12/31/23   90:11M                                    RDG Filings/FA           
  3/4/24  Cyclo Therapeutics, Inc.          8-K/A:9    12/27/23   11:172K                                   RDG Filings/FA           
 2/15/24  Sieger Markus                     4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/15/24  Ostronic Francis Patrick          4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/15/24  Toig Randall M.                   4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/15/24  Strattan Ce Rick                  4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/15/24  Wong Vivien                       4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/15/24  Conkling William                  4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/15/24  Shanahan William S                4          Director²   1:4K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
 2/14/24  Armistice Capital, LLC            SC 13G/A               1:88K  Cyclo Therapeutics, Inc.          Adviser Compliance … LLC 
 1/22/24  Cyclo Therapeutics, Inc.          8-K:8       1/17/24   11:163K                                   RDG Filings/FA           
12/28/23  Cross Shawn                       4          Director²   1:6K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
12/28/23  Cross Shawn                       3          Director²   1:3K   Cyclo Therapeutics, Inc.          RDG Filings/FA           
12/28/23  Cyclo Therapeutics, Inc.          8-K:3,5,9  12/26/23   12:1.2M                                   RDG Filings/FA           
12/28/23‡ Cyclo Therapeutics, Inc.          8-K:2,5,8,912/27/23   12:218K                                   RDG Filings/FA           
12/26/23  Cyclo Therapeutics, Inc.          8-K:5      12/26/23   11:176K                                   RDG Filings/FA           
12/18/23  Cyclo Therapeutics, Inc.          425                    1:115K Cyclo Therapeutics, Inc.          RDG Filings/FA           
12/18/23  Cyclo Therapeutics, Inc.          8-K:8      12/15/23   11:274K                                   RDG Filings/FA           
11/30/23  Cyclo Therapeutics, Inc.          425                    1:32K  Cyclo Therapeutics, Inc.          RDG Filings/FA           

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	425	Prospectus or Communication – Merger.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.